Anjali Sharma

This paper develops a targeted nanotherapeutic, FA-2DG-D-Niclo, which delivers niclosamide to FRβ-expressing macrophages, reducing endometriosis lesions and hyperalgesia in mice.

This study shows that systemic actinium-225 dendrimer-radioconjugates improve glioblastoma survival in mice, with enhanced efficacy when combined with temozolomide.

This paper develops a dendrimer-conjugated GCPII inhibitor (D-2PMPA) that improves cognition in MS mice without affecting disease severity.